96 related articles for article (PubMed ID: 19648661)
41. Maternal Foxp3 expressing CD4+ CD25+ and CD4+ CD25- regulatory T-cell populations are enriched in human early normal pregnancy decidua: a phenotypic study of paired decidual and peripheral blood samples.
Dimova T; Nagaeva O; Stenqvist AC; Hedlund M; Kjellberg L; Strand M; Dehlin E; Mincheva-Nilsson L
Am J Reprod Immunol; 2011 Jul; 66 Suppl 1():44-56. PubMed ID: 21726337
[TBL] [Abstract][Full Text] [Related]
42. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
[TBL] [Abstract][Full Text] [Related]
43. Treg cells are negatively correlated with increased memory B cells in pre-eclampsia while maintaining suppressive function on autologous B-cell proliferation.
Zeng B; Kwak-Kim J; Liu Y; Liao AH
Am J Reprod Immunol; 2013 Dec; 70(6):454-63. PubMed ID: 24033608
[TBL] [Abstract][Full Text] [Related]
44. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
45. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
46. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
[TBL] [Abstract][Full Text] [Related]
47. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.
Izcue A; Coombes JL; Powrie F
Immunol Rev; 2006 Aug; 212():256-71. PubMed ID: 16903919
[TBL] [Abstract][Full Text] [Related]
48. Phenotypic characterization of ex vivo CD4+CD25highCD127low immune regulatory T cells in allergic asthma: pathogenesis relevance of their FoxP3, GITR, CTLA-4 and FAS expressions.
Pietruczuk M; Eusebio M; Kraszula L; Kupczyk M; Kuna P
J Biol Regul Homeost Agents; 2012; 26(4):627-39. PubMed ID: 23241113
[TBL] [Abstract][Full Text] [Related]
49. Increased regulatory T cells in acute lymphoblastic leukaemia patients.
Idris SZ; Hassan N; Lee LJ; Md Noor S; Osman R; Abdul-Jalil M; Nordin AJ; Abdullah M
Hematology; 2016 May; 21(4):206-12. PubMed ID: 26907959
[TBL] [Abstract][Full Text] [Related]
50. Evidence for extrathymic T cell maturation after thymectomy in infancy.
Torfadottir H; Freysdottir J; Skaftadottir I; Haraldsson A; Sigfusson G; Ogmundsdottir HM
Clin Exp Immunol; 2006 Sep; 145(3):407-12. PubMed ID: 16907907
[TBL] [Abstract][Full Text] [Related]
51. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
52. Immunosuppressive properties of regulatory T cells generated by incubation of peripheral blood mononuclear cells with supernatants of human RPE cells.
Imai A; Sugita S; Kawazoe Y; Horie S; Yamada Y; Keino H; Maruyama K; Mochizuki M
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7299-309. PubMed ID: 23036994
[TBL] [Abstract][Full Text] [Related]
53. [The surface CD152 (CTLA-4) expression on peripheral blood lymphocytes in children with Hashimoto's thyroiditis].
Kucharska A; Górska E; Popko K; Wasik M; Rymkiewicz-Kluczyńska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):167-70. PubMed ID: 17020649
[TBL] [Abstract][Full Text] [Related]
54. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
[TBL] [Abstract][Full Text] [Related]
55. Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein.
Shreffler WG; Wanich N; Moloney M; Nowak-Wegrzyn A; Sampson HA
J Allergy Clin Immunol; 2009 Jan; 123(1):43-52.e7. PubMed ID: 19130927
[TBL] [Abstract][Full Text] [Related]
56. Expression and Clinical Correlations of Costimulatory Molecules on Peripheral T Lymphocyte Subsets of Early-Stage Severe Sepsis: A Prospective Observational Study.
Lu Y; An L; Liu Q; Li C
Shock; 2018 Jun; 49(6):631-640. PubMed ID: 29028770
[TBL] [Abstract][Full Text] [Related]
57. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
[TBL] [Abstract][Full Text] [Related]
58. Reduced expression of CD69 and adhesion molecules of T lymphocytes in asthmatic children receiving immunotherapy.
Huang JL; Ou LS; Tsao CH; Chen LC; Kuo ML
Pediatr Allergy Immunol; 2002 Dec; 13(6):426-33. PubMed ID: 12485318
[TBL] [Abstract][Full Text] [Related]
59. Regulatory T cells with CD62L or TNFR2 expression in young type 1 diabetic patients: relation to inflammation, glycemic control and micro-vascular complications.
El-Samahy MH; Adly AA; Ismail EA; Salah NY
J Diabetes Complications; 2015; 29(1):120-6. PubMed ID: 25113439
[TBL] [Abstract][Full Text] [Related]
60. Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia.
Salem ML; El-Shanshory MR; Abdou SH; Attia MS; Sobhy SM; Zidan MF; Zidan AA
Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):158-167. PubMed ID: 29388481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
